In the biopharma industry, post-merger layoffs are often a question of when and how many.
In the case of Amgen’s $27.8 billion buyout of Horizon, which was revealed last December and finalized earlier this month, they came quickly. Around 350 former Horizon employees are being told this week that their positions will be eliminated where there is "overlap with existing teams at Amgen," a spokesperson said.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,